Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease

AS Abdelhamid, TJ Brown, JS Brainard… - Cochrane Database …, 2018 - cochranelibrary.com
Background Researchers have suggested that omega‐3 polyunsaturated fatty acids from
oily fish (long‐chain omega‐3 (LCn3), including eicosapentaenoic acid (EPA) and …

[HTML][HTML] Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020

JK Innes, PC Calder - International journal of molecular sciences, 2020 - mdpi.com
The omega-3 (n-3) fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA), are found in seafood (especially fatty fish), supplements and concentrated …

Marine omega‐3 supplementation and cardiovascular disease: an updated meta‐analysis of 13 randomized controlled trials involving 127 477 participants

Y Hu, FB Hu, JAE Manson - Journal of the American Heart …, 2019 - Am Heart Assoc
Background Whether marine omega‐3 supplementation is associated with reduction in risk
of cardiovascular disease (CVD) remains controversial. Methods and Results This meta …

Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals

T Aung, J Halsey, D Kromhout, HC Gerstein… - JAMA …, 2018 - jamanetwork.com
Importance Current guidelines advocate the use of marine-derived omega-3 fatty acids
supplements for the prevention of coronary heart disease and major vascular events in …

Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes: a systematic review and meta …

NA Marston, RP Giugliano, KA Im, MG Silverman… - Circulation, 2019 - Am Heart Assoc
Background: Randomized trials of therapies that primarily lowered triglycerides have not
consistently shown reductions in cardiovascular events. Methods: We performed a …

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis

EC Rizos, EE Ntzani, E Bika, MS Kostapanos… - Jama, 2012 - jamanetwork.com
Context Considerable controversy exists regarding the association of omega-3
polyunsaturated fatty acids (PUFAs) and major cardiovascular end points. Objective To …

[HTML][HTML] Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease

AS Abdelhamid, N Martin, C Bridges… - … of systematic reviews, 2018 - ncbi.nlm.nih.gov
Background Evidence on the health effects of total polyunsaturated fatty acids (PUFA) is
equivocal. Fish oils are rich in omega‐3 PUFA and plant oils in omega‐6 PUFA. Evidence …

[HTML][HTML] A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and …

DD Alexander, PE Miller, ME Van Elswyk… - Mayo Clinic …, 2017 - Elsevier
Objective To conduct meta-analyses of randomized controlled trials (RCTs) to estimate the
effect of eicosapentaenoic and docosahexaenoic acid (EPA+ DHA) on coronary heart …

[HTML][HTML] The potential cardiometabolic effects of long-chain ω-3 polyunsaturated fatty acids: recent updates and controversies

JH Bae, H Lim, S Lim - Advances in Nutrition, 2023 - Elsevier
Various health-related effects of long-chain (LC) ω-3 PUFAs, EPA, and DHA have been
suggested. LC ω-3 PUFAs reduce TG concentrations and have anti-inflammatory …

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta …

SM Kwak, SK Myung, YJ Lee, HG Seo… - Archives of internal …, 2012 - jamanetwork.com
Background Although previous randomized, double-blind, placebo-controlled trials reported
the efficacy of omega-3 fatty acid supplements in the secondary prevention of cardiovascular …